Company overview
USCC
91450300729742527H
Id2
450300000020300
English Name
Guilin Pharmaceutical Co., Ltd.
Former names
-
Chinese Name
桂林南药股份有限公司
Entity type
Other Joint Stock Company (Non-Listed)
Authorized capital
¥28,503
Phone
+867732534572
Representative
彭小丹
Establishment date
22 June 2001
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 19 April 2023 | NG | 3004909000 | Spaq-Co 153Mg+500/25mg Dis Tb Bli/4'50Spaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4'50(Amodiaquine Hydrochloride Dispersible Tablets 153Mg (Base) + Sulfadoxine/Pyrimethamine Dispersible Tablets | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $3,785,140.00 | |
| 26 April 2023 | NG | 3004909000 | Spaq-Co 76.5Mg+250mg/12.5mg Dis Tb Bli/4 *50Spaq-Co 153Mg + 500/25Mg Dis Tb Bli/4*50(Amodiaquine Hydrochloride Dispersible Tablets 153Mg (Base)+ Sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg) | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $3,745,720.00 | |
| 15 December 2022 | NG | 3004909000 | Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride DispersibleTablets 153Mg(base)+Sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg) | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $3,369,732.13 | |
| 29 December 2022 | NG | 3004909000 | Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride DispersibleTablets 153Mg(base) +Sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg)Spaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride DispersibleTablets 76.5Mg(base | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $2,184,824.23 | |
| 14 March 2022 | NG | 3004901000 | Spaq-Co 153Mg+500/25mg Dis TbBli/4*50 (Amodiaquine Hydrochloride Dispersible Tablets, Recapture To To Add Up On The Value On Sgd C 10698 Of 7/2/22153Mg(base)+sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg) | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $2,119,514.06 | |
| 8 December 2022 | NG | 3004909000 | Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50(Amodiaquine Hydrochloride Dispersible +Sulfadoxine/Pyrimethamine DispersibleSpaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride DispersibleTablets 76.5Mg(base) +Sulfadoxine/ Pyrimethamine Dispersi | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $2,062,152.57 | |
| 17 May 2023 | NG | 3004909000 | Stc- Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50, Spaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride Dispersible Tablets 153Mg(base)+sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg) | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $1,883,400.00 | |
| 17 May 2023 | NG | 3004909000 | Stc- Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50, Spaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4*50(Amodiaquine Hydrochloride Dispersible Tablets 153Mg(base)+sulfadoxine/Pyrimethamine Dispersible Tablets 500/25Mg) | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $1,883,400.00 | |
| 7 December 2022 | NG | 3004909000 | Spaq-Co 153Mg+500/25mg Dis Tb Bli/4*50(Amodiaquine Hydrochloride Dispersible +Sulfadoxine/Pyrimethamine DispersibleSpaq-Co 76.5Mg+250/12.5mg Dis Tb Bli/4*50 (Amodiaquine Hydrochloride DispersibleTablets 76.5Mg(base) +Sulfadoxine/ Pyrimethamine Dispersi | National Malaria Elimination Programme | NG | Guilin Pharmaceutical Company Limited | $1,482,090.24 | |
| 27 January 2023 | NG | 3004909000 | Amodiaquine Hydrochloride (Humanitarian Goods) | United State Agency International Development Nigeria | NG | Guilin Pharmaceutical Company Limited | $1,262,080.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| Catholic Relief Services - Uscc | buyer | $2,601,501 | 8.56% |
| PT Bhineka Usada Raya | buyer | $624,750 | 2.06% |